Learning Objectives

1. Become familiar with the most common monogenic etiologies of neonatal/congenital diabetes, with emphasis on mutations in the KATP channel that can be treated with sulfonylureas.

2. Appreciate the difference in treatment, disease outcome and quality of life that can result from properly diagnosing patients with monogenic diabetes.

3. Recognize that learning more about individuals with rare disorders can teach us about areas of pathophysiology with broad applicability.


Session date: 
07/12/2018 - 4:30pm to 5:30pm CDT
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Siri Atma Greeley, M.D., Ph.D.